GPC vs TERN · P/E 21, rev $23.49B vs $6.12B cap
Genuine Parts Co (GPC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
GPC currently screens at market cap $17.60B and trailing P/E 20.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the GPC and TERN stock pages for the full models.
Not investment advice.